IE000KD0BZ68
IE000KD0BZ68
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
Loading chart...
Risk & Diversification Scores
Transparent evaluation of price volatility (SRI) and 4-dimensional portfolio diversification.
Volatility Risk Score
6/7 High
6 / 7 SRI PRIIPs Risk Class
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors.
Volatility (5Y)
22.8% p.a.
5-Year HorizonMax Drawdown (5Y)
-32.5%
Deepest DrawdownSharpe Ratio
0.17
Moderate (0.0 - 0.5)Rec. Holding Period
10+ Years
Investment HorizonSpeculative / High Risk: Score Basis:
Diversification Score
Focused (35% – 50%)
26 / 100 Portfolio Diversification
4 Dimensions: Holdings (30%) • Sectors (25%) • Industries (25%) • Regions (20%)
Focused weighting: Top holdings drive a major share of fund returns.
Top 10 Holdings
43.7%
FocusedEffective Holdings
~45
of 117 holdingsTop Sector
99.8%
HealthcareTop Region / Country
68.2%
United StatesElevated concentration in top individual holdings, leading sectors, or key regions.
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Stable Long-Term Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | +62.3% |
| 3 Years | 24.4% | -20.3% | 0.64 | +18.2% |
| 5 Years | 22.8% | -32.5% | 0.17 | — |
| 10 Years | — | — | — | — |
Notes & Warnings
⚠️ Elevated valuation: Avg P/E of 33.3
🟢 Deep market liquidity & capital coverage (Tier 1)
⚠️ Fund closure risk (< 50M € AUM)
🟡 Moderate analyst coverage (14.5 analysts)
🔴 Severe sector concentration risk: 100% in "Healthcare".
⚠️ Industry concentration: 37% in "Diagnostics & Research".
⚠️ Industry concentration: 48% in "Biotechnology".
🔴 30% of ETF holdings are unprofitable companies (severe cash-burn and fundamental financial risk).
⚠️ Growth estimates are concentrated: Top 3 growth drivers account for 51% of forward growth.
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).
🟢 Strong Defensive Buffer: 52% in crisis-resilient, non-cyclical sectors (consumer staples, healthcare, utilities).